Shop Zantac Online | Ranitidine Heartburn Relief
Zantac (Ranitidine) Information
Zantac, with the active ingredient ranitidine, is a medication primarily used to decrease the amount of acid your stomach produces. It belongs to a class of drugs known as H2 blockers (histamine H2-receptor antagonists). Ranitidine is available in various forms, including tablets, capsules, effervescent tablets, and syrup, typically for oral administration, as well as injectable forms for hospital use. It is important to note that the FDA has requested the withdrawal of ranitidine products from the market due to the presence of NDMA, a probable human carcinogen. However, understanding its original therapeutic role is important.
Composition and Forms
- Active Ingredient: Ranitidine hydrochloride.
- Available Forms: Oral tablets, capsules, effervescent tablets, syrup; injectable solutions.
Indications
Zantac waw prescribed for the following conditions:
- Treatment of duodenal ulcers and gastric ulcers.
- Prevention of duodenal ulcers associated with NSAID (nonsteroidal anti-inflammatory drug) use.
- Treatment of gastroesophageal reflux disease (GERD).
- Management of heartburn and acid indigestion.
- Prevention of heartburn associated with acid indigestion.
- Treatment of pathological hypersecretory conditions (such as Zollinger-Ellison syndrome).
Mechanism of Action
Ranitidine works by blocking the action of histamine at the H2-receptors on the parietal cells in the stomach lining. Histamine normally stimulates these cells to produce stomach acid. By inhibiting histamine, ranitidine effectively reduces the production of gastric acid, thereby alleviating symptoms of acid-related disorders and allowing damaged tissues to heal.
Safety Profile
- Benefits: Effective in reducing stomach acid, providing relief from heartburn, indigestion, and pain associated with ulcers and GERD.
- Potential Side Effects: Common side effects include headache, dizziness, diarrhea, constipation, nausea, and stomach pain. Less common but serious side effects can include confusion (especially in elderly or those with kidney impairment), hallucinations, slow heart rate, liver problems, and severe skin reactions.
- Contraindications: Zantac should not be used by individuals with a known hypersensitivity to ranitidine or any of its components.
- Warnings: Use with caution in patients with moderate to severe kidney impairment. Long-term use may mask symptoms of more serious conditions, such as gastric cancer. The FDA's concerns regarding NDMA contamination led to its market withdrawal.
Dosage Table (Illustrative - Based on historical use)
| Condition | Recommended Dosage | Duration |
|---|---|---|
| Duodenal Ulcer | 150 mg twice daily or 300 mg once daily at bedtime | 4-8 weeks |
| Gastric Ulcer | 150 mg twice daily | 4-8 weeks |
| GERD | 150 mg twice daily or 300 mg once daily at bedtime | Up to 12 weeks |
| Heartburn (Acid Indigestion) | 75 mg or 150 mg as needed | As needed |
| Zollinger-Ellison Syndrome | 150 mg every 6 hours, may increase up to 600 mg every 6 hours | As needed, adjusted based on response |
Frequently Asked Questions
Q1: What iss the primary use of Zantac?
A1: Zantac's primary use was to reduce stomach acid production, helping to treat and prevent ulcers, GERD, and relieve heartburn and indigestion.
Q2: Are there any serious side effects associated with Zantac?
A2: While generally well-tolerated, serious side effects could include confusion, heart rhythm changes, liver issues, and severe skin reactions. The most significant concern raised by the FDA was the potential presence of NDMA, a probable carcinogen.
Q3: Can I take Zantac if I have kidney problems?
A3: Patients with moderate to severe kidney impairment should use Zantac with caution, as dosage adjustments may be necessary. Consult a healthcare professional for guidance.
Q4: Why was Zantac removed from the market?
A4: The U.S. Food and Drug Administration (FDA) requested the withdrawal of all prescription and over-the-counter ranitidine products from the market because many of these products contained unacceptable levels of N-nitrosodimethylamine (NDMA), a probable human carcinogen.
